Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
What is Idebenone?
Idebenone (IDBN) is chemically named 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methylbenzoquinone, which was developed and marketed by Takeda Pharmaceutical Co., Ltd. in 1986 An intelligent stimulant; it has an activating effect on the function of pulling the body.
Function of Idebenone
Idebenone (trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013[update] the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe. Chemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10)..
Analysi | Specifications | |
Assay | ≥99% | |
Appearance | Yellow powder | |
Loss on Drying | ≤1.0% | |
Ash | ≤1.0% | |
As | ≤2.0ppm | |
Pb | ≤2.0ppm | |
Insoluble impurity content | ≤0.05% | |
Total Plate Count | ≤1000 cfu/g | |
Yeast &. Mold | ≤100 cfu/g | |
E.Coli | Negative | |
Salmonella | Negative | |
Conclusion |
Conform USP Standard.
|
|
Storage condition |
Store in cool & dry place, Keep away from strong light and heat.
|
|
Shelf life |
2 years when properly stored.
|